GlassScriptPhysician profile
Jerri D Robertson
NPI 1407070816
$903.67
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $37.09 · 2021: $338 · 2022: $212 · 2023: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $194.25 | 2021-2023 | Vraylar |
| Amgen INC. | $158.22 | 2019-2023 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $116.02 | 2019-2023 | Breztri |
| Novo Nordisk INC | $87.68 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.14 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $40.42 | 2020-2023 | Jardiance |
| Pfizer INC. | $37.97 | 2019-2023 | |
| Glaxosmithkline, LLC. | $31.95 | 2021 | |
| Mylan Specialty L.P. | $29.01 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $24.45 | 2019-2021 | |
| Eisai INC. | $18.80 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.41 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.39 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.08 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.12 | 2023 | Rexulti, Abilify Maintena |
| Seqirus USA INC | $13.55 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Apria Healthcare LLC | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerri Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.